Rubella is virus that causes a highly contagious infection. Symptoms of the infection include fever, skin rash, runny nose and pain in joints. In most cases they last for two to three days. A vaccine can prevent contagion. Rubella is also known as the “German measles” or the “Three day measles”.
Rubella testing is carried out to determine if a someone has sufficient antibodies to be protected against the rubella virus or if they have been infected by the same virus. A test reveals the number of IgM and IgG antibodies in the blood produced by the immune system and makes it possible to diagnose infection. Rubella testing is of paramount importance for women at or just prior to a pregnancy as it is vital to know if the mother’s body has enough antibodies to protect her fetus and herself from infection. Statistics show that 25% of babies born from mothers infected with rubella during the first three months of pregnancy exhibit birth defects. The clinical diagnosis of Rubella is not reliable so laboratory testing is necessary to confirm cases.
A blood sample is extracted from an arm vein for adults. For newborn babies sampling is usually done from the umbilical cord or the heel. No special preparation is required before blood sampling.
Method of test used
At Olympia Pavlidou Laboratory we use the enzyme-linked immunosorbent assay (ELISA, EIA) method of testing for Rubella.
Rubella testing is done at our lab in Limassol. Test results are available within XX hours from test initiation.
Test results parameters
<10=Absence of immunity
15-200=Long standing immunity
>200=High level of immunity